UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of June 2024
Commission File Number: 001-37385
Baozun Inc.
No. 1-9, Lane 510, West Jiangchang Road
Shanghai 200436
The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F ¨
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
Baozun Inc. |
|
|
|
|
By: |
/s/ Vincent Wenbin Qiu |
|
Name: |
Vincent Wenbin Qiu |
|
Title: |
Chief Executive Officer |
Date: June
14, 2024
Exhibit Index
Safe Harbor Statement
This announcement contains forward-looking statements.
These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,”
“aims,” “future,” “intends,” “plans,” “believes,” “estimates,”
“confident,” “potential,” “continues,” “ongoing,” “targets,” “guidance,”
“going forward,” “outlook” or other similar expressions. Statements that are not historical facts, including but
not limited to statements about Baozun’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve
inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking
statement, including but not limited to Baozun’s filings with the United States Securities and Exchange Commission and its announcements,
notices or other documents published on the website of The Stock Exchange of Hong Kong Limited. All information provided in this announcement
is as of the date hereof and is based on assumptions that Baozun believes to be reasonable as of this date, and Baozun undertakes no obligation
to update such information, except as required under applicable law.
Exhibit 99.1
Hong
Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,
make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
Under
our weighted voting rights structure, our share capital comprises Class A ordinary shares
and Class B ordinary shares. Each Class A
ordinary share entitles the holder to exercise one vote, and each Class B
ordinary share entitles the holder to exercise ten votes, respectively, on any resolution tabled at our general meetings, except as may
otherwise be required by law or by the Rules Governing the Listing
of Securities on The Stock Exchange of Hong Kong Limited or provided for in our memorandum and articles of association. Shareholders
and prospective investors should be aware of the potential risks of investing in a company with a weighted voting rights structure. Our
American depositary shares, each representing three of our Class A
ordinary shares, are listed on the Nasdaq Global Select Market in the United States under the symbol BZUN.
Baozun
Inc.
寶
尊 電 商 有 限 公 司 *
(A
company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock
Code: 9991)
APPOINTMENT
OF DIRECTORS
This
announcement is made by Baozun Inc. (the “Company”, together with its subsidiaries, the “Group”)
pursuant to Rule 13.51(2) of the Rules Governing the Listing of Securities (the “Listing Rules”) on
The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).
The
board (the “Board”) of directors (the “Directors”) of the Company is pleased to announce that each
of Dr. Jun Wang (“Dr. Wang”) and Ms. Bin Yu (“Ms. Yu”) has been appointed as
a Director with effect from June 14, 2024.
The
biographical details of Dr. Wang and Ms. Yu are set out as follows:
Dr. Jun
Wang, aged 47, has been appointed as a member of our board since June 14, 2024. He is the founding partner of ACCF Capital,
established in June 2021, which holds Champion Kerry Inc. Prior to founding ACCF Capital with focus on consumer and technology investment
across Asia Pacific region, Dr. Wang was a founding member and partner of L Catterton Asia from June 2010 to January 2021.
From October 2008 to March 2010, he served as a Senior Associate at McKinsey & Company and worked as a Manager at
Procter & Gamble Company from 2003 to 2006. Dr. Wang obtained his MBA from Harvard Business School in 2008, a D.Phil. in
Chemistry from Oxford University in 2002, and a B.Sc. from Peking University, China in 1998.
Dr. Wang
has entered into a director agreement with the Company for a term of three years, renewable upon expiry of the term, which may be terminated
by prior notice in writing served by either party on the other. Dr. Wang shall be subject to retirement by rotation at least once
every three years. Dr. Wang is not entitled to any directors’ fee.
As
of the date of this announcement, Champion Kerry Inc. is a company controlled by Dr. Wang and thus Dr. Wang is interested in
26,469,422 Class A ordinary shares of the Company held by Champion Kerry Inc.
Save
as disclosed above, as of the date of this announcement, Dr. Wang (i) does not hold other positions in the Company or other
members of the Group; (ii) has not held other directorship in any public companies the securities of which are listed on any securities
market in Hong Kong or overseas in the last three years; (iii) does not have other relationships with any Directors, senior management
or substantial or controlling shareholders (as defined in the Listing Rules) of the Company; and (iv) does not have other interests
in the shares of the Company within the meaning of Part XV of the SFO.
Ms. Bin
Yu, aged 54, served as our independent Director from May 2015 to May 2023. Following her tenure as an independent Director,
Ms. Yu has been appointed as a consultant to the Company since May 2023 and has rejoined our board as a member since June 14,
2024. She served as the chief financial officer for Lingochamp Information Technology (Shanghai) Co., Ltd. from 2017 to 2020. Ms. Yu
has served as an independent director of Zero2IPO Holdings Inc. since 2020, iDreamSky Technology Holdings Limited since 2018, and GDS
Holdings Limited since 2016, all of which are companies listed on the Hong Kong Stock Exchange. From 2015 to 2017, she served as the
chief financial officer of Innolight Technology Corp. From 2013 to 2015, she served as a director and the chief financial officer of
Star China Media Limited. From 2012 to 2013, she was a senior vice president of Youku Tudou Inc., and had responsibility for the company’s
investments in content production, mergers and acquisitions and strategic investments. She previously served as the chief financial officer
from 2011 to 2013, and the vice president of finance from 2010 to 2011, of Youku Tudou’s predecessor, Tudou Holdings Limited. Prior
to that, she worked at KPMG from 1999 to 2010 and was a senior manager of KPMG’s Greater China region. Ms. Yu received a master’s
degree in accounting from the University of Toledo, and an EMBA from Tsinghua University and INSEAD, respectively. Ms. Yu is a Certified
Public Accountant in the United States admitted by the Accountancy Board of Ohio.
Ms. Yu
has entered into a director agreement with the Company for a term of three years, renewable upon expiry of the term, which may be terminated
by prior notice in writing served by either party on the other. Ms. Yu shall be subject to retirement by rotation at least once
every three years. Ms. Yu is not entitled to any directors’ fee.
As
of the date of this announcement, Ms. Yu is interested in 6,723 Class A ordinary shares of the Company. In addition, Ms. Yu
is interested in 35,000 options and 10,086 restricted share units, representing equal number of Class A ordinary shares of the Company,
granted under the share incentive plans of the Company which remain unexercised or unvested as of the date of this announcement.
Save
as disclosed above, as of the date of this announcement, Ms. Yu (i) does not hold other positions in the Company or other members
of the Group; (ii) has not held other directorship in any public companies the securities of which are listed on any securities
market in Hong Kong or overseas in the last three years; (iii) does not have other relationships with any Directors, senior management
or substantial or controlling shareholders (as defined in the Listing Rules) of the Company; and (iv) does not have other interests
in the shares of the Company within the meaning of Part XV of the SFO.
Save
as disclosed above, as of the date of this announcement, there is no other information that is required to be disclosed pursuant to Rules 13.51(2)(h) to
(v) of the Listing Rules or any other matters that need to be brought to the attention of the shareholders of the Company or
the Stock Exchange in relation to the appointment of Dr. Wang and Ms. Yu.
The
Board would like to express its warm welcome to Dr. Wang and Ms. Yu on their new appointment.
|
By
order of the Board |
|
Baozun
Inc. |
|
Vincent
Wenbin Qiu |
|
Chairman |
Hong
Kong, June 14, 2024
As
at the date of this announcement, our board of directors comprises Mr. Vincent Wenbin Qiu as the chairman, Mr. Junhua Wu, Mr. Satoshi
Okada, Dr. Jun Wang and Ms. Bin Yu as directors, and Mr. Yiu Pong Chan, Mr. Steve Hsien-Chieng Hsia and Mr. Benjamin
Changqing Ye as independent directors.
*
For identification purposes only
Exhibit 99.2
Hong Kong Exchanges
and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no
representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from
or in reliance upon the whole or any part of the contents of this announcement.
Under our weighted
voting rights structure, our share capital comprises Class A ordinary shares and Class B ordinary shares. Each Class A
ordinary share entitles the holder to exercise one vote, and each Class B ordinary share entitles the holder to exercise ten votes,
respectively, on any resolution tabled at our general meetings, except as may otherwise be required by law or by the Rules Governing
the Listing of Securities on The Stock Exchange of Hong Kong Limited or provided for in our memorandum and articles of association. Shareholders
and prospective investors should be aware of the potential risks of investing in a company with a weighted voting rights structure. Our
American depositary shares, each representing three of our Class A ordinary shares, are listed on the Nasdaq Global Select Market
in the United States under the symbol BZUN.
Baozun Inc.
寶
尊 電 商 有 限 公 司 *
(A company controlled
through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock Code:
9991)
LIST OF DIRECTORS
AND THEIR ROLE AND FUNCTION
The members of the board of directors
(the “Board”) of Baozun Inc. (the “Company”) are set out below.
Directors
Mr. Vincent
Wenbin Qiu (Chairman and Chief Executive Officer)
Mr. Junhua
Wu
Mr. Satoshi
Okada
Dr. Jun Wang
Ms. Bin
Yu
Independent directors
Mr. Yiu
Pong Chan
Mr. Steve
Hsien-Chieng Hsia
Mr. Benjamin Changqing Ye
The Board has three Board committees.
The table below provides membership information of these committees on which each director of the Company serves.
|
Audit
Committee |
Compensation
Committee |
Nominating
and Corporate
Governance
Committee |
Mr. Vincent
Wenbin Qiu |
|
|
|
Mr. Junhua
Wu |
|
|
|
Mr. Satoshi
Okada |
|
|
|
Dr. Jun
Wang |
|
|
|
Ms. Bin
Yu |
|
|
|
Mr. Yiu
Pong Chan |
M |
C |
M |
Mr. Steve
Hsien-Chieng Hsia |
M |
M |
C |
Mr. Benjamin
Changqing Ye |
C |
M |
M |
Notes:
C Chairman
of the relevant Board committee
M Member
of the relevant Board committee
June 14,
2024
*
For identification purposes only
Baozun (NASDAQ:BZUN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Baozun (NASDAQ:BZUN)
Historical Stock Chart
From Dec 2023 to Dec 2024